Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
5,138,616
-
Total 13F shares
-
19,540
-
Share change
-
-10,711
-
Total reported value
-
$37,852
-
Price per share
-
$1.94
-
Number of holders
-
11
-
Value change
-
-$36,277
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of RedHill Biopharma Ltd. - American Depositary Shares (RDHL) as of Q2 2025
As of 30 Jun 2025,
RedHill Biopharma Ltd. - American Depositary Shares (RDHL) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,540 shares.
The largest 10 holders included
UBS Group AG, Federation des caisses Desjardins du Quebec, GAMMA Investing LLC, SBI Securities Co., Ltd., MORGAN STANLEY, RHUMBLINE ADVISERS, BANK OF AMERICA CORP /DE/, RAYMOND JAMES FINANCIAL INC, GROUP ONE TRADING LLC, and Financial Management Professionals, Inc..
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.